Specify a stock or a cryptocurrency in the search bar to get a summary
China Meheco Co Ltd
600056China Meheco Group Co., Ltd. engages in the pharmaceutical business in China and internationally. The company exports and imports natural medicines, pharmaceutical chemicals, medical equipment, and health products; produces and distributes pharmaceutical and health care products; and operates retail chain pharmacies. Its products include bulk pharmaceutical chemicals antibiotic fermentation and chemical synthesis tablets, injections, capsules, etc.; antibiotics; medicines for the treatment of cardio-cerebrovascular diseases, chronic diseases, and diabetes; antiviral; anti-infectious agents; gastrointestinal drugs; non-steroidal anti-inflammatory drugs; anti-allergic agents; specialty botanicals; western medicine preparations; Chinese patent medicines and herbal pieces; medical equipment and supplies; biological products; chemical raw materials; and nutritional and healthcare products. The company also plants, processes, warehouses, and transports ginseng, licorice, ephedra, rhubarb, rheum officinale, astragalus membranaceus, scutellaria baicalensis, fennel, and other herbs. China Meheco Group Co., Ltd. was founded in 1984 and is based in Beijing, China. Address: No. 18 Guangming Zhongjie, Beijing, China, 100061
Analytics
WallStreet Target Price
220.37 CNYP/E ratio
20.3333Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 600056
Dividend Analytics 600056
Dividend growth over 5 years
-43 %Continuous growth
–Payout Ratio 5 years average
30 %Dividend History 600056
Stock Valuation 600056
Financials 600056
Results | 2019 | Dynamics |